Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
SPINRAZA Royalties Revenue	221.90M	216.10M
WAINUA Royalties Revenue	43.00M	20.20M
TEGSEDI and WAYLIVRA Revenue	36.90M	34.20M
Commercial Licensing and Other Royalty Revenue	78.60M	22.60M
Total Commercial Revenue	380.40M	293.10M
Amortization from Upfront Payments Revenue	-	131.40M
Milestone Payments Revenue	-	106.40M
R&D License Fees Revenue	-	71.30M
Other R&D Services Revenue	-	23.50M
Collaborative Agreement Revenue	510.00M	332.60M
Eplontersen Joint Development Revenue	76.40M	79.40M
Total R&D Revenue	586.40M	412.00M
Revenue (Other)	-629.24M	-432.16M
Revenue (Total)	966.96M	705.14M

Updated Sep 30, 2025. Data Source: Fiscal.ai.